Michael David Garrison - Nov 26, 2023 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & President Medical
Signature
Donna Kalazdy, by power of attorney for Michael David Garrison
Stock symbol
BDX
Transactions as of
Nov 26, 2023
Transactions value $
$0
Form type
4
Date filed
11/28/2023, 08:21 PM
Previous filing
Aug 9, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +1.87K +36.28% $0.00 7.03K Nov 26, 2023 Direct F1
transaction BDX Common Stock Award $0 +3.13K +44.55% $0.00 10.2K Nov 26, 2023 Direct F2
transaction BDX Common Stock Tax liability $0 -1.65K -16.2% $0.00 8.51K Nov 26, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDX Stock Appreciation Rights Award $0 +10.4K $0.00 10.4K Nov 26, 2023 Common Stock 10.4K $238.89 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 Represents shares received upon vesting of performance based equity award.
F3 Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units as previously reported on Table I.
F4 The stock appreciation rights vest in four annual installments beginning November 26, 2024.